eviprostat

04/01/2008 - "The present findings raise the possibility that eviprostat could be an effective treatment for bladder overactivity associated with inflammation."
01/01/1995 - "Histologically, preoperative administration of Eviprostat improved the degree of prostatic inflammation. "
03/01/2014 - "Eviprostat suppresses the stromal proliferation and inflammation in the rat prostate after the establishment of NBP at least partly owing to inhibitory effect on CCL2/MCP-1 production in the prostate."
09/01/2013 - "Eviprostat-mediated suppression of increased bladder oxidative stress and inflammation caused by bladder OE may contribute to the improvement of BBF and bladder function by Eviprostat."
09/15/2009 - "These activities of Eviprostat may also contribute to the amelioration of prostate inflammation in BPH patients. "

05/01/2008 - "With supplemental administration of Eviprostat, significant improvement was observed in the symptoms of incomplete emptying, daytime frequency, intermittency, weak stream, total IPSS, sum of the IPSS subscores for voiding symptoms (intermittency, weak stream and straining), sum of the IPSS subscores for storage symptoms (daytime frequency, urgency and nocturia), and QOL score. "
04/01/2009 - "Significant improvements were observed in the incomplete emptying and frequency scores from the day after the start of administration, in the intermittence and straining scores from day 2, in the urgency and weak stream scores from day 3 and in the nocturia score from day 5. The QOL index significantly improved on day 7. In comparison with Eviprostat, Tamsulosin showed a stronger improvement tendency in the total IPSS, voiding symptoms score and incomplete emptying score and the difference was significant. "

09/01/2005 - "To study the efficacy and safety of Eviprostat for the treatment of benign prostatic hyperplasia (BPH). "
02/01/2008 - "We investigated the mechanisms by which Eviprostat, a phytotherapeutic drug for benign prostatic hyperplasia, influences bladder activity in rats. "
09/01/2005 - "[Clinical study of Eviprostat for the treatment of benign prostatic hyperplasia]."
01/01/1995 - "Eviprostat has been used as a non-hormonal and non-neuropharmacological treatment for benign prostatic hyperplasia (BPH) in Japan. "
01/01/1995 - "Clinical and retrospective evaluation of Eviprostat: a non-hormonal and non-neuropharmacological agent for benign prostatic hyperplasia."

06/06/2013 - "Eviprostat is a popular phytotherapeutic agent for the treatment of lower urinary tract symptoms (LUTS). "
09/01/2009 - "Eviprostat is an antioxidant, antiinflammatory phytotherapeutic agent widely used to treat lower urinary tract symptoms in BPH. "
01/01/2012 - "Suppressive Effects of Eviprostat, a Phytotherapeutic Agent, on Lower Urinary Tract Symptoms in Prostate Cancer Patients Treated with Brachytherapy."
05/01/2008 - "We examined the effectiveness of supplemental administration of Eviprostat in patients with benign prostatic hyperplasia (BPH) whose lower urinary tract symptoms (LUTS) caused by BPH were not adequately relieved by an alpha1-adrenoceptor blocker. "
02/01/2010 - "The present study investigated the effect of Eviprostat on the levels of the urinary oxidative stress marker 8-hydroxy-2'-deoxyguanosine (8-OHdG) in a rabbit model of surgical partial bladder outlet obstruction (PBOO) and in patients with lower urinary tract symptoms (LUTS) associated with BPH. "

03/01/2013 - "Therefore, Eviprostat may be a pharmacologically useful phytotherapeutic agent for cystitis."
04/01/2008 - "Effect of eviprostat on bladder overactivity in an experimental cystitis rat model."
04/01/2008 - "The purpose of this study was to investigate the effects of eviprostat, a phytotherapeutic drug, on bladder overactivity and inflammation in a cyclophosphamide (CYP)-induced cystitis rat model. "
03/01/2013 - "Repeat Eviprostat treatment significantly improved detrusor overactivity, down-regulated the expression of bladder pharmacological receptors and increased urinary cytokine levels in rats with cyclophosphamide induced cystitis. "